EUROFINS SCIENT (OTCMKTS:ERFSF) Given Consensus Rating of “Hold” by Analysts

Shares of EUROFINS SCIENT (OTCMKTS:ERFSFGet Free Report) have been assigned an average rating of “Hold” from the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company.

ERFSF has been the topic of several analyst reports. HSBC downgraded EUROFINS SCIENT to a “hold” rating in a research report on Friday, April 25th. Citigroup reissued a “neutral” rating on shares of EUROFINS SCIENT in a research report on Friday, July 25th. Finally, Hsbc Global Res downgraded EUROFINS SCIENT from a “strong-buy” rating to a “hold” rating in a research report on Friday, April 25th.

Check Out Our Latest Stock Analysis on EUROFINS SCIENT

EUROFINS SCIENT Stock Performance

OTCMKTS ERFSF opened at $75.83 on Thursday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. The business’s 50 day moving average price is $72.37 and its 200-day moving average price is $62.30. EUROFINS SCIENT has a fifty-two week low of $46.36 and a fifty-two week high of $83.02.

EUROFINS SCIENT Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Recommended Stories

Analyst Recommendations for EUROFINS SCIENT (OTCMKTS:ERFSF)

Receive News & Ratings for EUROFINS SCIENT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUROFINS SCIENT and related companies with MarketBeat.com's FREE daily email newsletter.